Skip to content

5 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy

Genetic variant interpretation in hypertrophic cardiomyopathy (HCM) evolves as population reference datasets expand, gene–disease validity assessments examine new candidate genes and additional functional and segregation evidence accumulates. Periodic re-interpretation is, therefore, necessary, particularly in pa...

A. Bakalakos, R. Lorca, D. Cannie et al. · 0 citations
Open access Oct 2026

Genotype-derived risk hierarchy in dilated cardiomyopathy

The risk of malignant ventricular arrhythmia (MVA) and end-stage heart failure (ESHF) in dilated cardiomyopathy (DCM) may vary by genotype.1 Comparative analyses remain limited. To compare clinical outcomes and risk predictors across genotypes. Carriers of pathogenic/likely pathogenic variants in DC...

D. Cannie, A. Bakalakos, P. Syrris et al. · 0 citations
Open access Sep 2026

Hypertrophic cardiomyopathy: a genome-wide association meta-analysis and polygenic risk score.

BACKGROUND Hypertrophic cardiomyopathy (HCM) is a heritable trait with marked variability in expression and outcomes. Our aims were to discover new genetic loci associated with HCM and to test the effect of a new polygenic risk score (PRS) on incidence, phenotype and outcomes stratified by genotype status. METHODS A...

Luis R. Lopes, Nay Aung, S. van Duijvenboden et al. · 0 citations
Open access Oct 2026

Gene-specific reclassification patterns of variants in hypertrophic cardiomyopathy.

In this large HCM cohort, variant re-evaluation resulted in a modest but clinically relevant reclassification of genetic variants, consistent with consolidation of locus-specific evidence and important given their association with adverse outcomes, despite modest hypertrophy.

A. Bakalakos, Rebeca Lorca, A. Protonotarios et al. · 0 citations
Open access Sep 2026

An Updated Evidence Assessment of the Genetic Causes of Dilated Cardiomyopathy.

BACKGROUND Evidence of the diverse genetic architecture of dilated cardiomyopathy (DCM) continues to emerge and requires reassessment of the clinical relevance of implicated disease genes. Building on the 2019-2020 Clinical Genome Resource evaluation, the DCM gene curation expert panel reconvened in 2024-2025 to conduc...

E. Jordan, Phoenix L. Grover, P. Parker et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.